Pharmacodynamics of prophylactic antirejection therapy with an anti interleukin-2 receptor monoclonal antibody (BT563) after heart and kidney transplantationHESSE, C. J; VAN GELDER, T; VAESSEN, L. M. B et al.Immunopharmacology (New York). 1995, Vol 30, Num 3, pp 237-246, issn 0162-3109Article

A double-blind, placebo-controlled study of monoclonal anti-interleukin-2 receptor antibody (BT563) administration to prevent acute rejection after kidney transplantationVAN GELDER, T; ZIETSE, R; MULDER, A. H et al.Transplantation. 1995, Vol 60, Num 3, pp 248-252, issn 0041-1337Article

Fluorine-18 FDG imaging in hepatocellular carcinoma using positron coincidence detection and single photon emission computed tomographyVERHOEF, C; VALKEMA, R; DE MAN, R. A et al.Liver (Copenhagen). 2002, Vol 22, Num 1, pp 51-56, issn 0106-9543Article